Lapatinib + Herceptin

[Julie2]

Effect of lapatinib on accumulation of inactive HER2 at the cell membrane and on antibody-dependent cellular cytotoxicity (ADCC) mediated by trastuzumab: A novel mechanism for the enhanced effects of combined anti-HER2 therapy.

http://www.abstract.asco.org/AbstView_55_31856.html